REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier is based in Colombia, with the head office in Bogota D.C.. The enterprise operates in the Ambulatory Health Care Services industry. The company was established on October 31, 2007. It currently has a total number of 1 (2017) employees. From the latest financial highlights, Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier reported a net sales revenue increase of 58.28% in 2021. Its’ total assets recorded a growth of 75.16%.

Headquarters
Cl 93B # 16 - 66 P 4 Cs 411
Bogota D.C.; Bogota D.C; Postal Code: 0922

Contact Details: Purchase the Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier report to view the information.
Outstanding Shares:
Purchase the Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier report to view the information.
Incorporation Date:
October 31, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorio De Citologia Y Patologia E U Dra Johanna Garavito Mazutier report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
58.28%
Total operating revenue
58.28%
Operating profit (EBIT)
569.57%
Net Profit (Loss) for the Period
N/A
Total assets
75.16%
Total equity
77.16%
Operating Profit Margin (ROS)
5.83%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
1.7%
Cash Ratio
1.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?